Holdings
Palo Alto Investors LP
As of Sep 30, 2026, Palo Alto Investors LP reported 49 positions worth US$628M. Largest: PTC Therapeutics, Inc., Iovance Biotherapeutics, Inc. and Insmed Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| PTC Therapeutics, Inc. | 875K | US$56.7M | −43,497 | Sep 30, 2026 |
| Iovance Biotherapeutics, Inc. | 3.47M | US$51.4M | −1.82M | Sep 30, 2026 |
| Insmed Incorporated | 444K | US$50.6M | +29,665 | Sep 30, 2026 |
| ACADIA Pharmaceuticals Inc. | 2.49M | US$50.1M | −378K | Sep 30, 2026 |
| BioMarin Pharmaceutical Inc. | 642K | US$38.5M | −40,322 | Sep 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 387K | US$33.1M | +38,506 | Sep 30, 2026 |
| United Therapeutics Corporation | 58,875 | US$31.9M | −3,712 | Sep 30, 2026 |
| Dyne Therapeutics, Inc. | 1.88M | US$30.3M | +234K | Sep 30, 2026 |
| Biogen Inc. | 133K | US$30M | −7,361 | Sep 30, 2026 |
| AnaptysBio, Inc. | 595K | US$29.9M | −8,225 | Sep 30, 2026 |